In the highly regulated and quality-driven pharmaceutical industry, the integrity of every compound used in the manufacturing process is critical. This article highlights the indispensable role of high-quality chemical intermediates, focusing on N-(3-chloro-4-fluorophenyl)-7-fluoro-6-nitroquinazolin-4-amine (CAS 162012-67-1), a key component in the synthesis of the targeted cancer therapy drug, Afatinib. We will discuss why sourcing reliable intermediates from expert manufacturers is crucial for optimizing synthesis processes and ensuring final product quality.

The intermediate N-(3-chloro-4-fluorophenyl)-7-fluoro-6-nitroquinazolin-4-amine, commonly referred to by its CAS number 162012-67-1, is essential for the efficient and effective production of Afatinib. Its characteristic white powder form and high purity levels (typically 98% or higher) are crucial parameters that directly impact the subsequent reaction steps and the overall yield and purity of the API. For any pharmaceutical company looking to buy N-(3-chloro-4-fluorophenyl)-7-fluoro-6-nitroquinazolin-4-amine, partnering with a reputable pharmaceutical intermediate manufacturer is the first step towards a robust and reliable synthesis pathway.

The availability and consistency of this Afatinib intermediate are paramount. Pharmaceutical manufacturers require a stable supply chain to maintain continuous production. This means selecting a N-(3-chloro-4-fluorophenyl)-7-fluoro-6-nitroquinazolin-4-amine supplier that has a proven track record of dependable delivery and adherence to specifications. Engaging with a Chinese manufacturer like NINGBO INNO PHARMCHEM provides access to advanced production capabilities and a deep understanding of the global pharmaceutical supply chain.

When evaluating the CAS 162012-67-1 price, it’s important to consider the total cost of ownership, which includes not only the purchase price but also the potential costs associated with quality issues or supply chain disruptions. Therefore, prioritizing quality and reliability over marginal price differences is a sound strategy. As a leading Afatinib intermediate supplier, NINGBO INNO PHARMCHEM offers competitive pricing without compromising on the superior quality of N-(3-chloro-4-fluorophenyl)-7-fluoro-6-nitroquinazolin-4-amine, ensuring that your pharmaceutical synthesis operations are both efficient and cost-effective.